Chordate Medical Holding AB (publ) (CMH.ST)
SEK 12.6
(-1.18%)
SEK 12.6
(-1.18%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.45 Million SEK | -130.01% |
| 2022 | -3.67 Million SEK | 87.32% |
| 2021 | -28.97 Million SEK | -86.48% |
| 2020 | -15.54 Million SEK | -336.87% |
| 2019 | -3.55 Million SEK | -232.86% |
| 2018 | 2.67 Million SEK | -47.2% |
| 2017 | 5.07 Million SEK | 77.57% |
| 2016 | 2.85 Million SEK | 1382.43% |
| 2015 | -222.69 Thousand SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -20.44 Million SEK | -141.78% |
| 2024 Q2 | -11.51 Million SEK | 43.69% |
| 2023 Q1 | -28.15 Million SEK | -665.95% |
| 2023 Q2 | -21.75 Million SEK | 22.74% |
| 2023 Q3 | -16.44 Million SEK | 24.41% |
| 2023 FY | -8.45 Million SEK | -130.01% |
| 2023 Q4 | -8.45 Million SEK | 48.58% |
| 2022 Q3 | -10.14 Million SEK | 35.67% |
| 2022 FY | -3.67 Million SEK | 87.32% |
| 2022 Q1 | -21.56 Million SEK | 25.59% |
| 2022 Q2 | -15.76 Million SEK | 26.89% |
| 2022 Q4 | -3.67 Million SEK | 63.75% |
| 2021 FY | -28.97 Million SEK | -86.48% |
| 2021 Q4 | -28.97 Million SEK | -278.81% |
| 2021 Q3 | -7.65 Million SEK | -46.9% |
| 2021 Q2 | -5.2 Million SEK | 46.91% |
| 2021 Q1 | -9.8 Million SEK | 36.88% |
| 2020 Q2 | -1.36 Million SEK | 70.73% |
| 2020 FY | -15.54 Million SEK | -336.87% |
| 2020 Q3 | -9.51 Million SEK | -594.9% |
| 2020 Q4 | -15.54 Million SEK | -63.29% |
| 2020 Q1 | -4.67 Million SEK | -31.54% |
| 2019 Q4 | -3.55 Million SEK | -433.51% |
| 2019 Q1 | 4.16 Million SEK | 55.4% |
| 2019 FY | -3.55 Million SEK | -232.86% |
| 2019 Q2 | 4.1 Million SEK | -1.42% |
| 2019 Q3 | -666.74 Thousand SEK | -116.25% |
| 2018 Q1 | -279.58 Thousand SEK | -105.51% |
| 2018 FY | 2.67 Million SEK | -47.2% |
| 2018 Q4 | 2.67 Million SEK | 72.63% |
| 2018 Q3 | 1.55 Million SEK | 128.44% |
| 2018 Q2 | -5.45 Million SEK | -1850.41% |
| 2017 Q2 | -4.48 Million SEK | 17.73% |
| 2017 FY | 5.07 Million SEK | 77.57% |
| 2017 Q3 | 2.23 Million SEK | 149.81% |
| 2017 Q1 | -5.44 Million SEK | -3593.67% |
| 2017 Q4 | 5.07 Million SEK | 127.17% |
| 2016 FY | 2.85 Million SEK | 1382.43% |
| 2016 Q4 | 155.92 Thousand SEK | 0.0% |
| 2016 Q1 | 7.82 Million SEK | 0.0% |
| 2015 FY | -222.69 Thousand SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acarix AB (publ) | -35.14 Million SEK | 75.945% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 100.689% |
| ADDvise Group AB (publ) | 1.22 Billion SEK | 100.689% |
| Arcoma AB | -1.12 Million SEK | -649.575% |
| Bactiguard Holding AB (publ) | 109.88 Million SEK | 107.695% |
| BICO Group AB (publ) | 927.9 Million SEK | 100.911% |
| Boule Diagnostics AB (publ) | 128.8 Million SEK | 106.565% |
| CellaVision AB (publ) | -56.94 Million SEK | 85.151% |
| Clinical Laserthermia Systems AB (publ) | -14.87 Million SEK | 43.166% |
| C-Rad AB (publ) | -127.6 Million SEK | 93.374% |
| Duearity AB (publ) | 10.23 Million SEK | 182.643% |
| Dignitana AB (publ) | 13.07 Million SEK | 164.657% |
| Episurf Medical AB (publ) | -52.7 Million SEK | 83.956% |
| Getinge AB (publ) | 5.4 Billion SEK | 100.156% |
| Scandinavian Real Heart AB (Publ) | -35.05 Million SEK | 75.879% |
| Iconovo AB (publ) | -10.75 Million SEK | 21.386% |
| Integrum AB (publ) | -10.47 Million SEK | 19.294% |
| Luxbright AB (publ) | -13.83 Million SEK | 38.879% |
| Mentice AB (publ) | -49.56 Million SEK | 82.941% |
| OssDsign AB (publ) | -162.78 Million SEK | 94.806% |
| Paxman AB (publ) | -11.41 Million SEK | 25.903% |
| Promimic AB (publ) | -50.32 Million SEK | 83.198% |
| Qlife Holding AB (publ) | 19.07 Million SEK | 144.338% |
| SciBase Holding AB (publ) | -27.32 Million SEK | 69.056% |
| ScandiDos AB (publ) | -1.53 Million SEK | -452.267% |
| Sectra AB (publ) | -772.85 Million SEK | 98.906% |
| Sedana Medical AB (publ) | -226.87 Million SEK | 96.273% |
| Senzime AB (publ) | -139.54 Million SEK | 93.941% |
| SpectraCure AB (publ) | -50.23 Million SEK | 83.168% |
| Stille AB | -178.5 Million SEK | 95.263% |
| Vitrolife AB (publ) | 1.22 Billion SEK | 100.689% |
| Xvivo Perfusion AB (publ) | -214.65 Million SEK | 96.061% |